Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The regulatory landscape is evolving: in February 2026, HHS announced that approximately 14 previously restricted peptides including BPC-157, TB-500, CJC-1295, Ipamorelin, and Sermorelin are expected to return to Category 1 compounding status
Pharmacology & therapeutics
If you study soft tissue or joint recovery, BPC-157s power to promote healing at the cell level is hard to beat
Decrease dose consideration: Persistent side effects including headaches, fatigue, or injection site reactions, excessive response (extremely rapid weight loss suggesting dose may be higher than needed), cost concerns when lower doses might achieve similar results
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATONAL AND EDUCATIONAL PURPOSES ONLY
In animal studies, along with one human study in people with muscular dystrophy, it works to build muscle if you get gene therapy to increase the bodys continuous production of follistatin
